aod9604 fat loss clinical trial AOD‑9604 Research in 2025: Late‑Night Hype, Quiet Data, and What Real People Actually Feel AOD9604 Versus GLP1 Agonists -

Fat Breakdown The GH and IGF-1 rise drives fat breakdown in visceral fat (the deep fat around your organs) more than in fat under the skin

However, if supplementing for confirmed deficiency, follow-up blood tests may be arranged by your GP to ensure adequacy of treatment

However, they may not be suitable or necessary for everyone

However, some people may experience some pain, swelling or redness at the injection site, and in much rarer cases headaches, itching or nausea

Once reconstituted, keep it refrigerated at 28C and use within the working shelf life described on the CoA

It tends to decrease with subsequent injections at the same dose as your body adapts